FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15885711000001108: Migraleve Ultra 50mg tablets (McNeil Products Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56355601000001119 Migraleve Ultra 50mg tablets (McNeil Products Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56355701000001112 Migraleve Ultra 50mg tablets (McNeil Products Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Is a Product containing precisely sumatriptan (as sumatriptan succinate) 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has active ingredient Sumatriptan succinate false Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has specific active ingredient Sumatriptan succinate true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Is a Migraleve Ultra true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Migraleve Ultra 50mg tablets (McNeil Products Ltd) Has basis of strength substance Sumatriptan true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Migraleve Ultra 50mg tablets (McNeil Products Ltd) 2 tablet Has AMP True Migraleve Ultra 50mg tablets (McNeil Products Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start